Latest news

AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals

AstraZeneca’s rare disease division, Alexion, has finalized a license agreement with JCR Pharmaceuticals valued at up to $825 million....

Life Sciences Voice Top Five Newsletter

Welcome to this week’s edition of the Life Sciences Voice Top Five Newsletter, your go-to source for the latest...

4DMT Accelerates Phase 3 Eye Gene Therapy Trials Despite 25% Workforce Reduction

4D Molecular Therapeutics (4DMT) is pressing ahead with its late-stage gene therapy ambitions even as it undergoes significant internal...

FDA Grants Accelerated Approval to Regeneron’s Lynozyfic for Advanced Multiple Myeloma

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Regeneron’s bispecific antibody linvoseltamab, now branded as...

Bezuclastinib Meets Primary Endpoint in Phase 3 Trial for Systemic Mastocytosis

Cogent Biosciences has announced that its Phase 3 trial...

Cosentyx Misses Primary Endpoint in Phase III Giant Cell Arteritis Trial

Novartis has reported that its anti-inflammatory drug Cosentyx did...

Sandoz Begins Construction on $440M Biosimilar Facility in Slovenia as Part of $1.1B Investment Drive

Sandoz has broken ground on a new $440 million biosimilar manufacturing facility in Brnik, Slovenia, as part of a...

Organon Says Goodbye to Endometriosis Drug Candidate After Phase 2 Failure

An Organon medication candidate, regarded as its most significant prospective chance, has failed a phase 2 study, leading the...

Shionogi Acquires Rights to BioVersys’ BV500 Program Targeting NTM Infections

Shionogi & Co. has entered into a new agreement with Swiss biotech BioVersys to acquire rights to its preclinical...

Atai–Beckley Merger Moves Forward After Psychedelic Nasal Spray Shows Promise in Depression Trial

Following promising Phase 2b results, Atai Life Sciences has...

Argenx and Unnatural Products Sign $1.5 Billion Deal to Develop Macrocyclic Peptide Therapies

Argenx has entered into an agreement with California-based Unnatural...

BerGenBio and Oncoinvent to Merge Amidst Former’s Cancer Drug Failure

BerGenBio, impacted by the unsuccessful outcome of its primary oncology medication, has chosen to merge with the Norwegian biotechnology...

Xoma Acquires Turnstone Biologics in $8M Deal Amid Industry Struggles

Xoma Royalty acquires struggling San Diego biotech Turnstone Biologics for $7.9M after halted trials and layoffs. Explore the details...

Sage Therapeutics to Lay Off All 338 Employees Following Supernus Acquisition

Sage Therapeutics will lay off all 338 employees following its $561M acquisition by Supernus. Discover how the deal, centered...
WhatsApp Image 2025 05 31 at 23.49.00 cd2174e0 min

AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals

AstraZeneca’s rare disease division, Alexion, has finalized a license...

AmerisourceBergen Sheds Its Decades-Old Identity to Emerge as Cencora

AmerisourceBergen, the pharmaceutical manufacturing and services firm, has retired...

Roche to lay off 300 to 400 employees in product development jobs

Roche’s executives, including CMO (Chief Medical Officer) Levi Garraway, claimed in a recorded video conference with staff acquired by Swiss Newspaper Blick

Popular

Most popular life news you must read today

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...

Regulatory

Life Sciences Voice Top Five Newsletter

Welcome to this week’s edition of the Life Sciences...

4DMT Accelerates Phase 3 Eye Gene Therapy Trials Despite 25% Workforce Reduction

4D Molecular Therapeutics (4DMT) is pressing ahead with its...

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with...

Research & Development

Market Access

French Company Orano Med Opens New Radiation Production Facility Near Indianapolis

In a nuclear medicine surge, industry leader Orano Med...

Gerresheimer Increases the Capabilities of Medical Systems in the USA

Gerresheimer, the maker of innovative systems and solutions and...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals

AstraZeneca’s rare disease division, Alexion, has finalized a license...

4DMT Accelerates Phase 3 Eye Gene Therapy Trials Despite 25% Workforce Reduction

4D Molecular Therapeutics (4DMT) is pressing ahead with its...